Company profile: Glympse Bio
1.1 - Company Overview
Company description
- Provider of noninvasive, predictive diagnostic solutions for monitoring multiple human diseases, using precisely engineered diagnostic agents that interrogate the body for disease states and carry the message to the urine for analysis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Glympse Bio
Fantex
HQ: United Kingdom
Website
- Description: Provider of polymeric biocide technology designed to combat bacteria and infectious diseases. Fantex technology represents a new generation and class of biocides that exploit natural bio-defence-mimetics and work differently from chemical biocides by using a novel method of bacterial cell killing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fantex company profile →
Cevec
HQ: Germany
Website
- Description: Provider of biopharmaceutical production expertise using a unique human cell-based expression system, developing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. CAP-Go enables production of proteins beyond antibodies, including complex glycosylated proteins that are difficult to express in conventional cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cevec company profile →
Centrillion Technologies
HQ: United States
Website
- Description: Provider of genomics and DNA analysis technologies for personalized medicine, life sciences research, and bioinformatics, offering whole genome genotyping assays; spatial transcriptomics at micron-scale resolution; high-throughput virus detection using ATOM chips; SARS-CoV-2 whole genome sequencing on QuadCore chips; VirusHunter assays for SARS-CoV-2 and Influenza A/B; and customizable ATOM chips for detecting pathogens, antibiotic resistance genes, and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centrillion Technologies company profile →
HighRes Biosolutions
HQ: United States
Website
- Description: Provider of modular laboratory automation systems and software for pharmaceutical, biotech, and academic research labs. Designs and builds innovative robotic systems and devices, including Nucleus hardware, Cellario integration software, MicroDock & MicroCart, CoLAB Flex collaborative robots, automated sample storage, and ancillary devices. Founded in 2004, headquartered in Woburn, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighRes Biosolutions company profile →
Bico
HQ: Sweden
Website
- Description: Provider of life science solutions to enable human organ and tissue production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bico company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Glympse Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Glympse Bio
2.2 - Growth funds investing in similar companies to Glympse Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Glympse Bio
4.2 - Public trading comparable groups for Glympse Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →